Phase 1 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with acute myeloid leukemia (AML) confirmed by laboratory testing, where the disease has either not responded to at least one prior treatment, or has come back after a period of remission — this also includes AML that developed from certain other blood or bone marrow conditions
- Adults aged 18 or older, of any sex, with a life expectancy of more than 3 months
- People whose kidneys are functioning well enough, based on a specific blood test measuring kidney filtering ability (confirm with trial site for exact threshold)
- People whose liver function tests are within an acceptable range, unless any abnormality is caused by the leukemia itself (confirm with trial site for exact values)
- People who are reasonably physically functional — rated at a level of 2 or below on a standard medical activity scale, meaning capable of self-care even if not able to do heavy physical work
- People who are not pregnant, or who are using reliable contraception during the treatment period
- People who are able to understand the study information and give their consent to participate voluntarily
Who may not be able to join:
- People whose AML is specifically the type called acute promyelocytic leukemia (APL)
- People whose leukemia has spread to the central nervous system (brain and spinal cord) and is currently active
- People with certain heart conditions, including a specific type of irregular heart rhythm measurement on an ECG, irregular heartbeats, a history of heart attack or heart failure within the past year, or coronary heart disease currently requiring medication
- People with a serious active infection that is not under control
- People who have had another non-blood cancer within the past 2 years
- People with a mental health condition that would make it difficult to take part in the study
- People who have previously received a solid organ transplant (a prior stem cell transplant may be acceptable, but not if the person is still experiencing graft-versus-host disease or is still on related medications)
- People who, in the opinion of the trial doctors, have any other condition that makes participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bing Xu, The First Aiffiliated hosptical of xiamen University
Phone: 18750918842
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete remission rate (CR); Complete Remission with Incomplete Count Recovery (CRi); Partial remission rate (PR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.